IP Library Granted Patent US 8,771,253
Granted Patent B2
US 8,771,253 · App. 13/572,348 · Granted Jul 8, 2014

System and method for percutaneously administering reduced pressure treatment using a flowable manifold

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,771,253
App. No.
13/572,348
Granted
Jul 8, 2014
Kind
B2
Abstract

A reduced pressure delivery system for applying a reduced pressure to a tissue site includes a manifold delivery tube having a passageway and a distal end, the distal end configured to be percutaneously inserted and placed adjacent the tissue site. A flowable material is provided and is percutaneously deliverable through the manifold delivery tube to the tissue site. The flowable material is capable of filling a void adjacent the tissue site to create a manifold having a plurality of flow channels in fluid communication with the tissue site. A reduced pressure delivery tube is provided that is capable of fluid communication with the flow channels of the manifold.

Claims (35)

1. A method of administering a reduced pressure therapy to a tissue site comprising:

percutaneously positioning a distal end of a manifold delivery tube adjacent a tissue site;

percutaneously delivering a flowable material through the manifold delivery tube to the tissue site, the flowable material being capable of filling a void adjacent the tissue site to create a manifold having a plurality of flow channels in fluid communication with the tissue site;

applying a reduced pressure to the tissue site through the manifold delivery tube and the flow channels of the manifold.

2. The method according to claim 1 , wherein the manifold is bioresorbable.

3. The method according to claim 1 , wherein the manifold serves as a scaffold for tissue growth.

4. The method according to claim 1 , wherein the manifold foams and undergoes a phase change in the presence of at least one of a bodily fluid and a bodily temperature.

5. The method according to claim 4 , wherein the manifold is a gel.

6. The method according to claim 1 , wherein the manifold further comprises a bioresorbable polymer dissolved in a solvent and mixed with sodium bicarbonate and citric acid.

7. The method according to claim 6 , wherein the bioresorbable polymer is one of a polylactide-co-glycolide (PLAGA) polymer and a polyethylene glycol-PLAGA copolymer.

8. The method according to claim 6 , wherein the solvent is methylene chloride.

9. The method according to claim 1 , wherein the flowable material is selected from the group consisting of a liquid, a slurry, a suspension, a viscous gel, a paste, a putty, and particulate solids.

10. The method according to claim 1 , wherein:

the flowable material undergoes a phase change in the presence of at least one of a bodily fluid and a bodily temperature; and

the flowable material includes a poragen that dissolves following curing of the flowable material, the dissolution of the poragen creating the plurality of flow channels.

11. The method according to claim 1 , wherein the flowable material includes microspheres having a coating that is capable of being selectively crosslinked following delivery of the flowable material to the tissue site.

12. The method according to claim 11 , wherein the coating is selectively crosslinked in response to at least one of heat, light, and a chemical.

13. The method according to claim 11 , wherein the microspheres following crosslinking create the plurality of flow channels.

14. The method according to claim 1 , wherein:

the flowable material is selected from the group consisting of a paste and a putty having an initial viscosity;

the viscosity of the flowable material decreases below the initial viscosity in the presence of shear forces during delivery to the tissue site; and

the viscosity of the flowable material reverts to the initial viscosity following delivery of the flowable material to the tissue site.

15. A method of delivering reduced pressure to a tissue site comprising:

inserting a delivery tube percutaneously to a void in the tissue site;

delivering a material through the delivery tube to the void;

forming flow channels in situ in the material; and

delivering a reduced pressure to the tissue site through the delivery tube and the flow channels.

16. The method of claim 15 , wherein forming the flow channels comprises hardening the material in the void into a solid state.

17. The method of claim 15 , wherein forming the flow channels comprises forming a foam from the material in the void.

18. The method of claim 15 , wherein forming the flow channels comprises dissolving poragens in the material.

19. The method of claim 15 , wherein forming the flow channels comprises dissolving sodium chloride in the material.

20. A method of delivering reduced pressure to a tissue site, the method comprising:

percutaneously inserting a delivery tube adjacent a tissue site;

percutaneously delivering a flowable material through the delivery tube to a void adjacent to the tissue site, the flowable material adapted to create a manifold in the void having a plurality of flow channels in fluid communication with the tissue site;

applying a reduced pressure to the tissue site through the delivery tube and the flow channels of the manifold.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: 3M INNOVATIVE PROPERTIES COMPANY
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 066445/0336 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 31, 2023
From: KCI LICENSING, INC.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 064790/0085 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Nov 7, 2019
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: KCI USA, INC.; KCI LICENSING, INC.
Reel/Frame 050966/0547 →
RELEASE OF SECURITY INTEREST REEL/FRAME 040098/0268 Recorded Feb 8, 2017
From: WILMINGTON TRUST
To: KCI USA, INC.
Reel/Frame 041666/0320 →
LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 7, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040291/0237 →
SECOND LIEN SECURITY AGREEMENT Recorded Sep 21, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040098/0268 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 3, 2012
From: JOHNSON, ROYCE W.; AMBROSIO, ARCHEL A.; SWAIN, LARRY D.; PAYNE, JOANNA
To: KCI LICENSING, INC.
Reel/Frame 029068/0539 →